Sciencare Medical is Drug Discovery in China that focus on release agent business. Founded in 2017. They cover business area such as developer, addiction treatment drug, opioid drug user, relapse, sustained and control drug addiction treatment, sustain-release agent, phase ii clinical trial, Naltrexone, WHO, naltrexone, subcutaneous implantation.
2017
( 7 years old in 2024 )
Release Agent
-
Building C2, Changfang Group Park
4th Planning Road, Pingshan District
Shenzhen, Guangdong
China
Private
developeraddiction treatment drugopioid drug userrelapsesustained and control drug addiction treatmentsustain-release agentphase ii clinical trialNaltrexoneWHOnaltrexonesubcutaneous implantation
* We use standard office opening hours in near Sciencare Medical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sciencare Medical is Drug Discovery business from China that founded in 2017 (7 years old in 2024), Sciencare Medical business is focusing on Release Agent.
Sciencare Medical headquarter office and corporate office address is located in Building C2, Changfang Group Park 4th Planning Road, Pingshan District Shenzhen, Guangdong China.
Sciencare Medical was founded in China.
In 2024, Sciencare Medical is currently focus on release agent sector.
Above is snippet of Google Trends for "release agent" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sciencare Medical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
